SGH Full Year 2025 Earnings: EPS Misses Expectations
SGH (ASX:SGH) Full Year 2025 Results
Key Financial Results
Revenue: AU$10.6b (flat on FY 2024).
Net income: AU$486.1m (up 4.7% from FY 2024).
Profit margin: 4.6% (up from 4.4% in FY 2024).
EPS: AU$1.20.
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
All figures shown in the chart above are for the trailing 12 month (TTM) period
SGH EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 44%.
The primary driver behind last 12 months revenue was the WesTrac segment contributing a total revenue of AU$6.11b (58% of total revenue). Notably, cost of sales worth AU$8.96b amounted to 85% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling AU$625.9m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how SGH's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Trade Distributors industry in Australia.
Performance of the Australian Trade Distributors industry.
The company's shares are down 8.7% from a week ago.
Risk Analysis
Before you take the next step you should know about the 1 warning sign for SGH that we have uncovered.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Amer Sports Raises Annual Outlook, Analysts Probe China Strength
Amer Sports, Inc. (NYSE:AS) shares are trading lower on Tuesday. The company reported second-quarter adjusted earnings per share of 6 cents, beating the analyst consensus estimate of 3 cents. Quarterly sales of $1.24 billion (+23% year over year) outpaced the Street view of $1.18 Sachs analyst Brooke Roach reiterated the Buy rating on Amer Sports, with a price forecast of $45. According to Roach, Amer Sports delivered strong results despite high investor expectations, with a solid beat and raised annual outlook even as tariffs posed a headwind. He noted Salomon brand drove the outperformance, showing sequential acceleration despite tougher comparisons, with omni-channel sales up 28%, operating profit up 35% year-over-year, and margins expanding over 700 basis points. However, Technical Apparel growth was more in line with expectations, with comps at +15% but showing slower sequential growth. Roach added that Greater China momentum and DTC strength were highlights, while management's third-quarter revenue guidance above consensus signals continued momentum into the next quarter. Roach highlighted key downside risks for Amer Sports, including slower-than-expected growth in Greater China, weaker brand momentum if innovation slows, and potential concerns around the corporate structure such as its Cayman Islands incorporation and changes in backing from major shareholders. The analyst also pointed to risks from limited or lower-quality real estate availability. Roach said that the team will look for more detail on the call regarding revenue drivers by geography and channel, focusing on the durability of China's growth momentum and the slight sequential slowdown in the Americas. The analyst added they also want an update on management's view of Arc'teryx's comp potential across regions and the related margin flow-through opportunity. Price Action: AS shares are trading lower by 6.28% to $35.15 at last check Tuesday. Read now:Photo via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Amer Sports Raises Annual Outlook, Analysts Probe China Strength originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
an hour ago
- Yahoo
MedX Holdings, Inc. (OTC: MEDH) Med X Holdings Q2 2025 Investor Update: We're at an Inflection Point
Sales up; on track for ~$1.5M FY25 revenue. Las Vegas lounge approaching approvals. Leaf-trak POS rolling out Q3. Pipeline building in Florida and California. Austin, Texas, Aug. 19, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MedX Holdings, Inc. (OTC: MEDH) Med-X Holdings Q2 2025 Investor Update: We're at an Inflection PointSales up; on track for ~$1.5M FY25 revenue. Las Vegas lounge approaching approvals. Leaf-trak POS rolling out Q3. Pipeline building in Florida and California. Austin, Texas — August 19, 2025 — Med-X Holdings, Inc. (OTC: MEDH), parent of Lazydaze +Coffeeshop, today issued its Q2 2025 investor update. The headline is simple: sales increased in Q2 and we remain on pace for approximately $1.5 million in full-year 2025 revenue. The business is tightening execution, our lounge pipeline is maturing, and our technology platform Leaf-trak is moving from build to rollout. Hans Enriquez, CEO of Med-X Holdings: 'We're optimists because we've earned the right to be. Q2 was a step forward, and Q3–Q4 should be better. Las Vegas is closing in on approvals, Houston is next up with a new Lazydaze franchise, Florida and California lounge deals are active, and Leaf-trak is ready to pilot. This industry is shifting—we're at the beginning of the end of cannabis prohibition—and we intend to be on offense- we want to meet and beat our expectations!' Why Med-X, Why Now — Investor Highlights Revenue Momentum: Q2 growth; FY25 tracking to ~$1.5M. Near-Term Openings: Las Vegas consumption lounge advancing toward opening pending final drawings and approvals. Franchise Expansion: Welcoming of Houston—the newest Lazydaze franchisees—targeting a Q4 2025 or early 2026 opening. Active Lounge Pipeline: Florida and California deals in motion. Operating Traction in NM: Our New Mexico store continues to gain ground in a fully recreational market. Tech Platform Going Live: Leaf-trak—our vertically integrated lounge POS + payments stack—piloting in Q3 and commercializing in Q4 via Smart Brand Digital, with expected revenue contribution starting Q4 2025 into Q1 2026. Regulatory Tailwinds: We navigated Texas turbulence (including a veto and special-session noise) and see constructive signals at the federal level. If rescheduling progresses, capital access and institutional participation should improve—exact timing remains uncertain, but the direction of travel is clear. Leaf-trak: Built for Lounges, Not Just Retail What it is: A hospitality-grade platform for consumption lounges that includes: A retail- and restaurant-centric POS configured for lounge workflows (table/service flows, compliance prompts). Integrated payment processing directly in the POS. BioTrack integration for track-and-trace where required. Online ordering and to-go pickup from Lazydaze stores where permitted by law. Why it matters: Lounges run on hospitality economics, not just dispensary checkout. Leaf-trak is designed to increase throughput, reduce compliance risk, and create new revenue moments (service, events, food, and beverage) that most retail-centric POS systems don't handle well. Roadmap: Future-proofed for the next 5–10 years, with planned AI-assisted workflows and (subject to regulations and partner banks) digital currency acceptance with conversion to U.S. dollars. Near-Term Catalysts (What to Watch) Las Vegas — final drawings and approvals → opening sequence. Houston (Lazydaze) franchise build-out → targeted Q4 2025 / early 2026 opening. Florida & California — convert active lounge negotiations to signed agreements. Leaf-trak — Q3 pilots, Q4 commercial release via Smart Brand Digital; begin revenue ramp Q4 2025–Q1 2026. Operating KPIs — continued sales growth and NM traction as a model for rec-market execution. The Reality (and Why We're Confident) Regulation is noisy. We fought through a choppy Texas session and ongoing special-session uncertainty. We're still standing and still growing. Capital has been tight. We built Leaf-trak to create a second engine (software + payments) that compounds alongside new lounges. Industry consolidation is coming. Operators will need hospitality-grade systems, compliant workflows, and brand systems that travel. That's the lane we own with Lazydaze and leaftrak. A Note to Our Long-Time Investors Thank you for your patience and belief. The last stretch wasn't pretty—but we did the hard, unglamorous work. Q2 confirms the direction; the next 12 months are about velocity and conversion. We intend to make this one of our strongest years to date. A Note to New Investors If you believe cannabis is crossing the chasm—from prohibition to regulated mainstream—we're building the platforms (lounges + tech) that capture that shift. Talk to us. We're prioritizing strategic capital and partnerships that accelerate openings, technology deployments, and market entries. About MedX Holdings, Inc. (OTC: MEDH) MedX Holdings is building a portfolio for cannabis retail, hospitality, and technology through its subsidiaries, including Dazed Inc., Smart Brand Digital, and Lazydaze + Coffeeshop. The company is focused on franchise development, cannabis/hemp retail innovation, and regulatory-compliant tech solutions for the industry. Our mission is to deliver exceptional products and unforgettable hospitality experiences through our Lazydaze +Coffeeshop brands and franchises. We are committed to leading the industry by developing and expanding a successful portfolio of licensed and franchised brands. For more information, please visit and Follow us @medxholdings and the CEO @the1onlyhans on X Forward-Looking Statements This release contains forward-looking statements within the meaning of the federal securities laws. Actual results may differ materially due to various risks and uncertainties. Investor & Media Contact Contact Information:Raji Bhakta- President Operations / IRMedX Holdings, Inc.210 438 2750raji@ CONTACT: Contact Information: Raji Bhakta- President Operations / IR MedX Holdings, Inc. 210 438 2750 raji@
Yahoo
3 hours ago
- Yahoo
Movie theatre business grew in 2024, but still short of pre-pandemic highs: StatCan
OTTAWA — Statistics Canada says movie theatre business grew in 2024 but still hadn't reached its pre-pandemic peaks. Every two years, the agency releases a look at the state of movie theatres. Its report for 2024 showed operating revenues hit $1.6 billion last year, up 12 per cent from 2022. Statistics Canada says that marked a rebound from COVID-era restrictions, but still fell 13.1 per cent below the record of $1.9 billion seen in 2018. Theatre attendance was also stagnating, the agency says, at roughly two-thirds the levels seen six years earlier. Statistics Canada says the average ticket price rose to $12.54 in 2024, up 5.5 per cent from 2022 and 31.9 per cent from 2020. This report by The Canadian Press was first published Aug. 19, 2025. The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
